The U.S. Patent and Trademark Office has issued a patent on innovations that could diagnose and treat lung diseases, including pulmonary emphysema. The innovations were created by Matthias A. Clauss of the Indiana University School of Medicine.
More than 3.1 million Americans have been diagnosed with emphysema. Emphysema and chronic bronchitis are the two components of chronic obstructive pulmonary disease, or COPD. The disease has no effective treatment that reverses its course or halts its progression. The patented innovation is a method for diagnosing and treating a patient with emphysema or COPD by detecting certain proteins and neutralizing their actions.
The innovation was disclosed to the IU Innovation and Commercialization Office. The mission of the office is to drive innovation to the market for the benefit of the public, the university and innovators for state, national and global commerce. IU personnel can disclose an invention online.